Química en Ciencias Farmacéuticas
Departamento
![Foto de Química en Ciencias Farmacéuticas](/img/noimage.png)
![Foto de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas](/img/noimage_org.png)
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (15)
2021
-
Human amylin aggregates release within exosomes as a protective mechanism in pancreatic β cells: Pancreatic β-hippocampal cell communication
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1868, Núm. 5
-
Osteoporosis Remission and New Bone Formation with Mesoporous Silica Nanoparticles
Advanced Science, Vol. 8, Núm. 16
2018
-
Activation of bombesin receptor Subtype-3 by [D-Tyr 6 ,β-Ala 11 ,Phe 13 ,Nle 14 ]bombesin 6-14 increased glucose uptake and lipogenesis in human and rat adipocytes
Molecular and Cellular Endocrinology, Vol. 474, pp. 10-19
-
C-reactive protein expression in adipose tissue of children with acute appendicitis
Pediatric Research, Vol. 84, Núm. 4, pp. 564-567
-
Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's Disease
Molecular Nutrition and Food Research, Vol. 62, Núm. 23
2017
-
Colon cancer modulation by a diabetic environment: A single institutional experience
PLoS ONE, Vol. 12, Núm. 3
-
Huntington's Disease and Diabetes: Chronological Sequence of its Association
Journal of Huntington's Disease, Vol. 6, Núm. 3, pp. 179-188
-
Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes
Cardiovascular Diabetology, Vol. 16, Núm. 1
2016
-
Adverse Effects of Diabetes Mellitus on the Skeleton of Aging Mice
Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 71, Núm. 3, pp. 290-299
2013
-
Amylin exerts osteogenic actions with different efficacy depending on the diabetic status
Molecular and Cellular Endocrinology, Vol. 365, Núm. 2, pp. 309-315
-
Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes
Molecular and Cellular Endocrinology, Vol. 367, Núm. 1-2, pp. 109-115
-
Characterization of skeletal alterations in a model of prematurely aging mice
Age, Vol. 35, Núm. 2, pp. 383-393
-
Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors
Journal of Pharmacology and Experimental Therapeutics, Vol. 347, Núm. 1, pp. 100-116
2012
-
Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states
Journal of Molecular Endocrinology, Vol. 48, Núm. 1, pp. 37-47
2011
-
Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state
Peptides, Vol. 32, Núm. 10, pp. 2077-2085